Trial intelligence / Profile preview

Losartan for Lymphoid Tissue Fibrosis in HIV

NCT01852942Phase 2Completed

Sponsor
University of Minnesota
Start
Sep 2014
Primary completion
Jul 2019
Countries
1
01

Overview

A Phase 2 trial of losartan in human immunodeficiency virus infection (HIV), sponsored by University of Minnesota. Started Sep 2014; status: completed.

02

Drugs

losartan
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01852942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01852942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call